Clovis Oncology Inc EV/EBIT
What is the EV/EBIT of Clovis Oncology Inc?
The EV/EBIT of Clovis Oncology Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Clovis Oncology Inc
Companies with ev/ebit similar to Clovis Oncology Inc
- Novan Inc has EV/EBIT of N/A
- Providence Resources P.l.c has EV/EBIT of N/A
- Pioneer Power Solutions Inc has EV/EBIT of N/A
- Apollo Gold has EV/EBIT of N/A
- Electreon Wireless Ltd has EV/EBIT of N/A
- Clover Leaf Capital Corp has EV/EBIT of N/A
- Clovis Oncology Inc has EV/EBIT of N/A
- Innate Pharma has EV/EBIT of N/A
- Perimeter Medical Imaging AI has EV/EBIT of N/A
- Pmv Pharmaceuticals Inc has EV/EBIT of N/A
- Cluey Ltd has EV/EBIT of N/A
- SPORTTOTAL AG has EV/EBIT of N/A
- Christopher & Banks has EV/EBIT of N/A